ABSTRACT:
Enzymatic activity measurement has a broad application in drug screening, diagnosis and disease staging and molecular profiling. However, conventional immunopeptidemetric assays (IMPA) exhibit low fluorescence signal-to-noise ratios, preventing reliable measurements at lower concentrations in the clinically important pM~nM range.
Berkeley Lab researchers demonstrated a highly sensitive measurement of protease activity using nanoplasmonic resonator (NPR). NPRs enhance Raman signals by 6.1x1010 times in a highly reproducible manner, enabling fast detection of protease and enzyme activity, such as Prostate Specific Antigen (paPSA), in real time, at a sensitivity level of 6 pM (0.2 ng/ml) with a dynamic range of three orders of magnitude.
Experiments on extracellular fluid from paPSA-positive cells demonstrate specific detection in a complex bio-fluid background. This method offers a fast, sensitive, accurate and one-step approach to detect the protease activities in very small sample volumes.
STATUS: Published patent application (WIPO 2009/094058). Available for licensing or collaborative research.
FOR MORE INFORMATION:
SEE THESE OTHER BERKELEY LAB TECHNOLOGIES IN THIS FIELD:
Single Step, Real Time Protein Kinase Detection for Biological Screening, JIB-2452
Molecular Ruler fro Label-free Measurement of Protein-DNA Interactions, IB-2320
Protease-based Cancer Screening Using Nanoliter Samples, IB-2240
REFERENCE NUMBER: JIB-2421
